MOSCOW, 22 Aug — RIA Novosti. Created in conjunction with the defense Ministry, the vaccine will protect the person received it from the coronavirus for a period of more than two years, said the Director, National research centre (NRC) of epidemiology and Microbiology named Gamalei Alexander Ginzburg.
Clinical trials of the vaccine created by SIC and defense to 18 volunteers began June 18 in the Burdenko hospital. Planned to be completed by the end of July.
“the Vaccine is administered twice. Moreover, the same gene (the vaccine uses adenovirus containers for delivering genes encoding a protein “corona” of coronavirus — ed.) is introduced on different carriers, which gives the opportunity not just to get a protective protective immunity, but to his extended period of time,” said Ginzburg in an interview with the newspaper “Red star”.
“This approach ensures with a high probability that the person who received the vaccine in the booster (enhancing — ed.) form, will be protected from possible infection by the coronavirus, at least for two years, and possibly for a longer period,” he added.
the Doctor said that this long-term effect of the drug was proved in a joint work nits and medical establishments of the defense Ministry in the African Guinea on vaccines against Ebola virus.
